Access to Infrastructure & R&D Support service
Early Translational Bioanalysis Support
Provided by Anapharm Bioanalytics - Anapharm Europe S.L.U. · Spain
Service description
This service supports innovative biotechnology and pharmaceutical companies during early translational and preclinical development stages requiring flexible and scientifically driven bioanalytical support. The service includes exploratory pharmacokinetic (PK), pharmacodynamic (PD) and biomarker bioanalysis for small molecules and biologics using LC-MS/MS and ligand-binding assay platforms. Support may include feasibility studies, assay optimisation, non-GLP bioanalysis and early-stage analytical strategies adapted to the specific maturity and objectives of each programme. The goal of the service is to help innovators generate high-quality bioanalytical data to support translational decision-making, candidate progression and preparation for subsequent regulated development stages. Activities are tailored to the specific needs of each EIC beneficiary and may include scientific discussions, study design support, analytical planning and customised bioanalytical execution. The service is delivered by specialised scientific and project management teams with extensive experience supporting innovative drug development programmes.
Project timelines, deliverables and study scope are defined on a case-by-case basis depending on analytical complexity, study design, material availability and project requirements. Service availability is subject to laboratory capacity and scheduling alignment with the sponsor team.